Dermatologic toxicity of chemotherapeutic agents

AS Payne, WD James, RB Weiss - Seminars in oncology, 2006 - Elsevier
Due to its high metabolic rate, skin represents one of the major target organs of
chemotherapy-associated toxicity. Reactions range from common, nonspecific …

Cutaneous reactions to chemotherapeutic agents

RA Koppel, EE Boh - The American journal of the medical sciences, 2001 - Elsevier
The task of evaluating a cutaneous eruption in the patient receiving chemotherapy can be
quite formidable. Most of the time, these patients are receiving a multitude of agents and …

An update on drug-induced pigmentation

AF Nahhas, TL Braunberger, IH Hamzavi - American journal of clinical …, 2019 - Springer
Drug-induced pigmentation accounts for up to 20% of all cases of acquired pigmentation. A
thorough review of medical history and previous and ongoing medications as well as a …

[HTML][HTML] Clinical management of cutaneous adverse events in patients on chemotherapy: a national consensus statement by the Spanish Academy of Dermatology …

O Sanmartín, C Beato, HJ Suh-Oh, I Aragón… - Actas Dermo …, 2019 - Elsevier
Although the arrival of new chemotherapy drugs and combinations has brought progress in
terms of cancer patient survival, they entail many adverse effects that can compromise …

Possible mechanisms by which topical 5‐fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study

Y Gauthier, T Anbar, S Lepreux… - International …, 2013 - Wiley Online Library
The combination of skin ablation and 5‐Fluorouracil (5‐FU) ointment was previously tried in
the treatment of vitiligo, and good results were specifically reported in glabrous skin without …

Persistent serpentine supravenous hyperpigmented eruption associated with docetaxel

I Aydogan, A Kavak, AH Parlak, M Alper… - Journal of the …, 2005 - Wiley Online Library
Various mucocutaneous reactions have been reported with the use of systemic docetaxel.
We describe a 47‐year‐old man who developed a persistent serpentine supravenous …

Study of cutaneous adverse effects of cancer chemotherapy

A Menon, S Handattu, J Shetty… - Clinical Dermatology …, 2018 - journals.lww.com
Background: Cancer is a leading cause of mortality and morbidity in both developed and
developing parts of the world with the disease burden projected to grow exponentially in …

Serpentine supravenous hyperpigmentation induced by chemotherapy: a systematic review

J Shan, BC Obiakor, J Cheng, RA Francois… - Archives of …, 2024 - Springer
Serpentine supravenous hyperpigmentation (SSH) describes increased skin pigmentation
that develops in the area immediately overlying the vessels through which …

Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine

D Marcoux, R Anex, P Russo - Journal of the American Academy of …, 2000 - Elsevier
A 15-year-old boy experienced a macular serpentine erythematous eruption that subsided
with a persistent hyperpigmentation overlying the superficial venous network of the left …

Manejo clínico de los eventos adversos cutáneos en pacientes tratados con quimioterapia: consenso nacional de la Academia Española de Dermatología y …

O Sanmartín, C Beato, HJ Suh-Oh, I Aragón… - Actas Dermo …, 2019 - Elsevier
A pesar del avance que ha supuesto en la supervivencia de los pacientes oncológicos, la
aparición de nuevos agentes quimioterápicos y nuevas combinaciones, estos han traído …